Geode Capital Management, LLC Syros Pharmaceuticals, Inc. Transaction History

Geode Capital Management, LLC

  • $1.12 Trillion
  • Q2 2024

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$0.69 - $1.21 $346,048 - $606,839
-501,520 Reduced 50.9%
483,711 $465,000
Q1 2022

May 13, 2022
BUY
$1.02 - $3.8 $32,671 - $121,717
32,031 Added 3.36%
985,231 $1.17 Million
Q4 2021

Feb 11, 2022
BUY
$3.26 - $4.66 $311,506 - $445,281
95,554 Added 11.14%
953,200 $3.11 Million
Q3 2021

Nov 12, 2021
SELL
$4.08 - $5.66 $443,912 - $615,819
-108,802 Reduced 11.26%
857,646 $3.83 Million
Q2 2021

Aug 13, 2021
BUY
$5.01 - $7.48 $668,534 - $998,131
133,440 Added 16.02%
966,448 $5.27 Million
Q1 2021

May 12, 2021
BUY
$7.19 - $14.95 $1.75 Million - $3.63 Million
242,906 Added 41.16%
833,008 $6.23 Million
Q4 2020

Feb 12, 2021
BUY
$6.66 - $14.66 $62,557 - $137,701
9,393 Added 1.62%
590,102 $6.4 Million
Q3 2020

Nov 13, 2020
BUY
$8.69 - $14.47 $146,930 - $244,658
16,908 Added 3.0%
580,709 $5.13 Million
Q2 2020

Aug 13, 2020
BUY
$5.21 - $11.03 $341,848 - $723,722
65,614 Added 13.17%
563,801 $6.01 Million
Q1 2020

May 14, 2020
BUY
$4.46 - $9.2 $100,978 - $208,297
22,641 Added 4.76%
498,187 $2.95 Million
Q4 2019

Feb 13, 2020
BUY
$4.52 - $10.1 $109,026 - $243,622
24,121 Added 5.34%
475,546 $3.29 Million
Q3 2019

Nov 12, 2019
BUY
$7.14 - $11.65 $39,291 - $64,109
5,503 Added 1.23%
451,425 $4.69 Million
Q2 2019

Aug 14, 2019
BUY
$5.5 - $9.75 $854,650 - $1.52 Million
155,391 Added 53.49%
445,922 $4.13 Million
Q1 2019

May 14, 2019
BUY
$5.51 - $9.59 $225,155 - $391,876
40,863 Added 16.37%
290,531 $2.66 Million
Q4 2018

Feb 13, 2019
BUY
$5.55 - $11.34 $128,948 - $263,473
23,234 Added 10.26%
249,668 $1.39 Million
Q3 2018

Nov 13, 2018
BUY
$9.74 - $12.92 $111,912 - $148,450
11,490 Added 5.35%
226,434 $2.7 Million
Q2 2018

Aug 14, 2018
BUY
$10.16 - $13.65 $521,990 - $701,296
51,377 Added 31.41%
214,944 $2.19 Million
Q1 2018

May 15, 2018
BUY
$9.47 - $12.98 $642,179 - $880,199
67,812 Added 70.82%
163,567 $2.12 Million
Q4 2017

Feb 13, 2018
BUY
$8.45 - $17.48 $7,300 - $15,102
864 Added 0.91%
95,755 $931,000
Q3 2017

Nov 14, 2017
BUY
$13.52 - $23.75 $149,666 - $262,912
11,070 Added 13.21%
94,891 $1.4 Million
Q2 2017

Aug 14, 2017
BUY
N/A
83,821
83,821 $1.35 Million

About Syros Pharmaceuticals, Inc.

SYRS Quotes by TradingView
  • Ticker SYRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,236,200
  • Market Cap $43.1M
  • Description
  • Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...
More about SYRS
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email